| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |